help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whittaker, P. G.
Right arrow Articles by Lind, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whittaker, P. G.
Right arrow Articles by Lind, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Journal of Clinical Endocrinology & Metabolism, Vol 53, 863-866, Copyright © 1981 by Endocrine Society


ARTICLES

Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin

PG Whittaker, T Wilcox and T Lind

The heterogeneity of serum PRL in a hyperprolactinemic but fertile woman (Patient A) was studied by gel chromatography. Ninety percent of her PRL eluted with the void volume as "big, big" PRL and only 6% coincided with monomeric "little" PRL. Sera from a woman who had hyperprolactinemia associated with infertility (Patient B) and a normal woman (Patient C) exhibited the usual heterogeneous distribution, where 5% and 19%, respectively, eluted as big, big PRL and 76% and 65%, respectively, eluted as little PRL. Serial dilutions of the serum from Patient A displayed nonparallelism to the lines obtained from similar dilutions of both PRL standard and serum from a normal woman, suggesting possible immunological differences among the three forms of the circulating hormone. This finding, together with reports that suggest big, big PRL has a low receptor affinity, may account for the apparent lack of any biological effect upon Patient A from her sustained hyperprolactinemia.


This article has been cited by other articles:


Home page
Clin. Chem.Home page
L. Beltran, M. N. Fahie-Wilson, T. J. McKenna, L. Kavanagh, and T. P. Smith
Serum Total Prolactin and Monomeric Prolactin Reference Intervals Determined by Precipitation with Polyethylene Glycol: Evaluation and Validation on Common ImmunoAssay Platforms
Clin. Chem., October 1, 2008; 54(10): 1673 - 1681.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
A. Leanos-Miranda, G. Cardenas-Mondragon, A. Ulloa-Aguirre, I. Isordia-Salas, A. Parra, and J. Ramirez-Peredo
Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome
Lupus, May 1, 2007; 16(5): 342 - 349.
[Abstract] [PDF]


Home page
EndocrinologyHome page
N. Hattori, Y. Nakayama, K. Kitagawa, T. Li, and C. Inagaki
Development of Anti-PRL (Prolactin) Autoantibodies by Homologous PRL in Rats: A Model for Macroprolactinemia
Endocrinology, May 1, 2007; 148(5): 2465 - 2470.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N Hattori, Y Nakayama, K Kitagawa, T Ishihara, Y Saiki, and C Inagaki
Anti-prolactin (PRL) autoantibody-binding sites (epitopes) on PRL molecule in macroprolactinemia.
J. Endocrinol., August 1, 2006; 190(2): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Kavanagh, T. J. McKenna, M. N. Fahie-Wilson, J. Gibney, and T. P. Smith
Specificity and Clinical Utility of Methods for the Detection of Macroprolactin
Clin. Chem., July 1, 2006; 52(7): 1366 - 1372.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Leanos-Miranda and G. Cardenas-Mondragon
Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity
Rheumatology, January 1, 2006; 45(1): 97 - 101.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Gibney, T. P. Smith, and T. J. McKenna
The Impact on Clinical Practice of Routine Screening for Macroprolactin
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3927 - 3932.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Hattori, K. Ikekubo, Y. Nakaya, K. Kitagawa, and C. Inagaki
Immunoglobulin G Subclasses and Prolactin (PRL) Isoforms in Macroprolactinemia Due to Anti-PRL Autoantibodies
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3036 - 3044.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Fahie-Wilson
In Hyperprolactinemia, Testing for Macroprolactin Is Essential
Clin. Chem., September 1, 2003; 49(9): 1434 - 1436.
[Full Text] [PDF]


Home page
Hum ReprodHome page
C. Mounier, J. Trouillas, B. Claustrat, R. Duthel, and B. Estour
Macroprolactinaemia associated with prolactin adenoma
Hum. Reprod., April 1, 2003; 18(4): 853 - 857.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Schlechte
The Macroprolactin Problem
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5408 - 5409.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Hekim, H. Alfthan, J. T. Leinonen, and U.-H. Stenman
Effect of Incubation Time on Recognition of Various Forms of Prolactin in Serum by the DELFIA Assay
Clin. Chem., December 1, 2002; 48(12): 2253 - 2256.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Vallette-Kasic, I. Morange-Ramos, A. Selim, G. Gunz, S. Morange, A. Enjalbert, P.-M. Martin, P. Jaquet, and T. Brue
Macroprolactinemia Revisited: A Study on 106 Patients
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Leanos-Miranda, D. Pascoe-Lira, K. A. Chavez-Rueda, and F. Blanco-Favela
Persistence of Macroprolactinemia Due to Antiprolactin Autoantibody before, during, and after Pregnancy in a Woman with Systemic Lupus Erythematosus
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2619 - 2624.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Leslie, C. H. Courtney, P. M. Bell, D. R. Hadden, D. R. McCance, P. K. Ellis, B. Sheridan, and A. B. Atkinson
Laboratory and Clinical Experience in 55 Patients with Macroprolactinemia Identified by a Simple Polyethylene Glycol Precipitation Method
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2743 - 2746.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Pascoe-Lira, G. Duran-Reyes, I. Contreras-Hernández, L. Manuel-Apolinar, F. Blanco-Favela, and A. Leaños-Miranda
Frequency of Macroprolactinemia Due to Autoantibodies against Prolactin in Pregnant Women
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 924 - 929.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Hattori and C. Inagaki
Anti-Prolactin (PRL) Autoantibodies Cause Asymptomatic Hyperprolactinemia: Bioassay and Clearance Studies of PRL-Immunoglobulin G Complex
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3107 - 3110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society